Topic Editors

1. Proteomics Center, Institute of Biochemistry, Vilnius University Life Sciences Center, Sauletekio al. 7, LT-10257 Vilnius, Lithuania
2. MAP Kinase Resource, Bioinformatics, Melchiorstrasse 9, CH-3027 Bern, Switzerland
1. Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie National Research Institute of Oncology, 02781 Warsaw, Poland
2. Department of Experimental Pharmacology, Mossakowski Medical Research Institute, Polish Academy of Sciences, 02106 Warsaw, Poland

Kinases in Cancer and Other Diseases, 2nd Edition

Abstract submission deadline
31 October 2024
Manuscript submission deadline
31 December 2024
Viewed by

Topic Information

Dear Colleagues,

Protein kinases comprise a large family of enzymes that catalyze protein phosphorylation. The human genome contains 518 protein kinase genes. Phosphorylation is one of the major mechanisms for regulating various cellular processes, such as proliferation, the apoptosis cell cycle, growth, apoptosis, differentiation, etc. The deregulation of kinase activity can result in significant changes in these processes. Furthermore, deregulated kinases are often oncogenic and essential for the survival and spreading of cancer cells. There are different ways in which kinases are involved in cancers, including misregulated expression and/or amplification, mutation, chromosomal translocation, abnormal phosphorylation, and epigenetic regulation. In order to further investigage these functions, there are various scientific projects assessing the importance of kinases in cancers as well as several other diseases, such as polycystic kidney disease, glomerulonephritis, neurodegeneration, retinal degeneration, lung inflammation, etc. In clinical science the major two kinase investigation routes are (1) using kinases as biomarkers in cancer prognostics and diagnostics and (2) treating cancers with kinase inhibitors and/or monoclonal antibodies. This Topic will highlight current and innovative research achievements in these areas.

Dr. Jonas Cicenas
Dr. Anna M. Czarnecka
Topic Editors


  • protein kinases
  • protein phosphorylation
  • kinase inhibitors
  • cancers
  • diseases

Participating Journals

Journal Name Impact Factor CiteScore Launched Year First Decision (median) APC
4.2 4.0 2012 18.8 Days CHF 2700 Submit
5.5 8.3 2011 19.2 Days CHF 2700 Submit
5.2 7.4 2009 18.2 Days CHF 2900 Submit
6.0 9.0 2012 18.8 Days CHF 2700 Submit
International Journal of Molecular Sciences
5.6 7.8 2000 16.8 Days CHF 2900 Submit
4.6 4.7 2004 15.7 Days CHF 2900 Submit

Preprints is a platform dedicated to making early versions of research outputs permanently available and citable. MDPI journals allow posting on preprint servers such as prior to publication. For more details about reprints, please visit

Published Papers

This Topic is now open for submission.
Back to TopTop